Agilent, 799775-904, AdvanceBio RP-mAb C4, 2.1 x 50 mm, 3.5 µm

AdvanceBio RP-mAb C4, 2.1 x 50 mm, 3.5 µm. A reversed-phase C4 HPLC column with superficially porous particles and a wide (450 Å) pore size designed for mAbs and other larger proteins for intact or subunit analysis.

Specifications:
Brand: AdvanceBio RP mAb C4
Hardware: SS
Inner Diameter (ID): 2.1 mm
LC Platform: Stainless Steel
Length: 50 mm
Maximum Temperature: 90 °C
Part Number Application Domain: Biopharma
Part Number Application: Intact & Subunit AnalysisMonoclonal Antibodies (mABs)Proteins
Particle Size: 3.5 µm
Particle Type: Superficially Porous
Phase: C4
Pore Size: 450 Å
Pressure Rating: 600 bar
Separation Mode: Reversed Phase
Shipping Solvent: Acetonitrile/Water
Technique: LCLC & LC/MS
UNSPSC Code: 41115711
pH Range: 1-8

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
Engineered to deliver exceptional performance in the analysis of monoclonal antibodies and related biotherapeutics, this high-efficiency reversed-phase column features a pore size and C4 phase optimized for large biomolecules. With dimensions of 2.1 x 50 mm and a particle size of 3.5 microns, it ensures robust resolution and reliable reproducibility for intact mAb, antibody fragments, and protein characterization workflows.

Ideal for use in quality control, method development, and research environments, this column is designed to withstand high pressures, making it suitable for fast and high-throughput analyses. Its advanced particle technology provides superior peak shapes and minimizes sample carryover, allowing precise identification and quantitation of critical quality attributes.

Compatible with a wide range of high-performance liquid chromatography and ultra-high-performance liquid chromatography systems, including Agilent 1100, 1200, 1260 Infinity, 1290 Infinity, and comparable platforms from other manufacturers, this product integrates seamlessly with current laboratory workflows. It also works effectively in conjunction with mass spectrometric detection for detailed structural elucidation. Researchers benefit from reliable batch-to-batch consistency and confidence in method transferability across laboratories, making this column an essential tool for biopharmaceutical development and routine analysis.